6 Treatment of acute promyelocytic leukaemia
- 1 March 1996
- journal article
- Published by Elsevier in Bailliere's Clinical Haematology
- Vol. 9 (1) , 107-128
- https://doi.org/10.1016/s0950-3536(96)80039-4
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaBlood, 1993
- Molecular monitoring of the myl/retinoic acid receptor-alpha fusion gene in acute promyelocytic leukemia by polymerase chain reactionBlood, 1992
- A PML/retinoic acid receptor alpha fusion transcript is constantly detected by RNA-based polymerase chain reaction in acute promyelocytic leukemiaBlood, 1992
- Hypercalcaemia due to all-trans retinoic acidThe Lancet, 1992
- A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patientsBlood, 1991
- All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]Blood, 1990
- Primary therapy of acute promyelocytic leukemia: results of amsacrine- and daunorubicin-based therapyBlood, 1984
- Acute promyelocytic leukemia in childrenMedical and Pediatric Oncology, 1981
- A Variant Form of Hypergranular Promyelocytic Leukemia (M3)Annals of Internal Medicine, 1980
- Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative GroupBritish Journal of Haematology, 1976